Risk factors for HPV DNA detection in middle-aged women

Sexually Transmitted Diseases

Volumn 23, Issue 6, 1996, Pages 504-510

  Muñoz, Nubia ^a   Kato, Ikuko ^a   Bosch, F Xavier ^b   Eluf Neto, José ^c   De Sanjosé, Silvia ^b   Ascunce, Nieves ^j   Gili, Miguel ^d   Izarzugaza, Isabel ^e   Viladiu, Pablo ^f   Tormo, Maria José ^g   Moreo, Pilar ^h   Gonzalez, Luis Carlos ⁱ   Tafur, Luis ^k   Walboomers, Jan M M ^l   Shah, Keerti V ^m  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Catedra de Med Preventiva y Social   (Spain)

^e Registro del Cancer de Euzkadi   (Spain)

^f Duran i Reynals Hospital   (Spain)

^g Instituto Murciano de Investigación Biosanitaria Arrixaca   (Spain)

^h Registro de Cancer   (Spain)

ⁱ Delegacion Terr de Bienestar Social   (Spain)

^j Programa de Cancer de Mama   (Spain)

^k UNIVERSIDAD DEL VALLE   (Colombia)

^l VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^m JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; BRAZIL; COLOMBIA; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL BEHAVIOR; SPAIN; UTERINE CERVIX CANCER; WART VIRUS;

EID: 10544234613     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199611000-00012     Document Type: Article

References (40)

1. Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52:743-749.
2. Bosch FX, Muñoz N, de Sanjosé S, et al. Human papillomavirus and CIN III: A case-control study in Spain and Colombia. Cancer Epidemiol Biomarker Prev 1993; 2:423-431.
3. Peng H, Liu S, Mann V, Rohan T, Rawls W. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer 1991; 47:711-716.
4. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69:114-119.
5. Morrison EAB, Ho GYF, Vermund SH, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 1991; 49:6-13.
6. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papilloma infection. N Engl J Med 1992; 327:1272-1278.
7. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-964.
8. Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 1994; 271:1181-1188.
9. Olsen AO, Gjøfen K, Sauer T, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: A population-based case-control study. Int J Cancer 1995; 61:312-315.
10. IARC. Human papillomavirus. Monographs on the Evaluation of the Carcinogenic Risks to Humans. vol 64, Lyon: International Agency for Research on Cancer, 1995.
11. Schneider A, Koutsky LA. Natural history and epidemiological features of genital HPV infection. In: Muñoz N, Bosch FX, Shah KV, Meheus A, eds. The Epidemiology of Cervical Cancer and Human Papillomavirus. Lyon: International Agency for Research on Cancer, 1992:25-52.
12. Guerrero E, Daniel RW, Bosch FX, et al. Comparison of ViraPap, Southern hybridization and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol 1992; 30:2951-2959.
13. Walboomers JMM, Melkert PWJ, Van den Brule AJC, Snijders PJF, Meijer CJLM. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In: Herrington CS, McGee JOD, eds. Diagnostic Molecular Pathology. A Practical Approach. Oxford: IRL Press, 1992;153-172.
14. Fisher M, Rosenfeld WD, Burk RD. Cervicovaginal human papillomavirus infection in suburban adolescents and young adults. J Pediatr 1991; 119:821-825.
15. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillornaviruses in the lower genital tract of pregnant women. Int J Cancer 1987; 40:198-201.
16. Lorincz AT, Schiffman MH, Jaffurs WJ, Marlow J, Quinn AP, Temple GF. Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. Am J Obstet Gynecol 1990; 162:645-651.
17. de Villiers E-M, Wagner D, Schneider A, et al. Human papillomavirus DNA in women without and with cytological abnormalities: results of 5-year follow-up study. Gynecol Oncol 1992; 44:33-39.
18. Kjaer SK, Engholm G, Teisen C, et al. Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study. Am J Epidemiol 1990; 131:669-682.
19. Villa LL, Franco ELF, Ludwig Institute for Cancer Research Human Papillomavirus Study Group. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 1989; 81:332-340.
20. Moscicki A-B, Palefsky J ,Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. Pediatr Res 1990; 28:507-513.
21. Azocar J, Abad SMJ, Acosta H, et al. Prevalence of cervical dysplasia and HPV infection according to sexual behavior. Int J Cancer 1990; 45:622-625.
22. Bornstein J, Ben-David Y, Pascal B, et al. Occult human papillomavirus cervical infection: Reverse DNA hybridization detection and review of the literature. Israel J Obstet Gynecol 1993; 2:58-65.
23. Kjaer SK, de Villiers E-M, Çaglayan H, et al. Human papillomavirus and Herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark): A seeond look. Br J Cancer 1993; 67:830-837.
24. Melkert PWJ, Hopman E, van den Brule AJC, et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53:919-923.
25. Ley C, Bauer HM, Reinngold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83:997-1003.
26. Wheeler CM, Parmenter CA, Hunt WC, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center. Sex Transm Dis 1993; 20:286-289.
27. Hildesheini A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1993; 20:279-285.
28. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20:274-278.
29. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-240.
30. Ho DWT, Field PR, Sjogren-Jansson E, Jeansson S, Cunningham AL. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods 1992; 36:249-264.
31. Wang SP, Grayston JT. Human serology in TRIC-LGV (Chlamydia trachomatis) infection with micro immunofluorescence. J Infect Dis 1974; 130:388-397.
32. Breslow NE, Day NE. Statistical Methods in Cancer Research. In: The Analysis of Case-Control Studies, vol 1. Lyon: International Agency for Research on Cancer, 1980.
33. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J. Cancer Incidence in Five Continents. vol 6. Lyon: International Agency for Research on Cancer, 1992.
34. Franco EL. Measurement errors in epidemiological studies of human papillomavirus and cervical cancer. In: Muñoz N, Bosch FX, Shah KV, Meheus A, eds. The epidemiology of cervical cancer and human papillomavirus. Lyon: International Agency for Research on Cancer, 1992:181-197.
35. Bosch FX, Muñoz N, de Sanjosé S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52:750-758
36. Muñoz N, Bosch, FX, de Sanjosé S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2:423-431.
37. Bosch FX, Muñoz N, de Sanjosé S, et al. Importance of the human papillomavirus endemicity in the incidence of cervical cancer: An extension of the hypothesis on sexual behaviour. Cancer Epidemiol Biomarkers Prev 1994; 3:375-379.
38. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-1371.
39. Mitrani-Rosenbaum S, Tsvieli R, Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol 1989; 70:2227-2232.
40. Mittal R, Tsutsumi K, Pater A, Pater MM. Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones. Obstet Gynecol 1993; 81:5-12.